Agenus and Noetik Partner to Develop AI-Based Biomarkers Using Virtual Cell Models

Agenus has partnered with San Francisco-based Noetik to develop AI-enabled predictive biomarkers for its lead immunotherapy regimen, botensilimab (BOT) and …

Continue ›››

Isomorphic Labs Appoints Ben Wolf as Chief Medical Officer, Expands to U.S. Hub in Cambridge

Isomorphic Labs has appointed Dr. Ben B. Wolf as Chief Medical Officer and opened a new U.S. office in Cambridge, …

Continue ›››

Ryght AI Raises $3M to Automate Clinical Trial Site Activation with Agentic AI

Laguna Beach–based Ryght AI, co-founded by Simon Arkell and Alex Dickinson in mid-2023, develops agentic and generative AI tools to accelerate …

Continue ›››

AstraZeneca Signs $5.3B AI Drug Discovery Deal with CSPC for Chronic Disease Programs

AstraZeneca has signed a licensing and co-discovery agreement with CSPC Pharmaceutical Group worth up to $5.3 billion, including $110 million …

Continue ›››

Insilico Medicine Completes Oversubscribed Series E, Bringing Total Funding to $123 Million

Insilico Medicine has finalized its Series E round at $123 million, up from the $110 million first announced in March …

Continue ›››

Sofinnova's Startups Get NVIDIA GPU Access to Accelerate Biological AI Models

Sofinnova Partners has announced a collaboration with NVIDIA to provide high-performance AI computing infrastructure to select companies in its life …

Continue ›››

Insilico Medicine Launches its Multimodal Generative Chemistry Model on AWS Marketplace

Insilico Medicine has released Nach01, a large-scale generative chemistry foundation model, on the AWS Marketplace. The model combines structural and …

Continue ›››

MIT and Recursion Launch Boltz-2, Open-Source AI Foundation Model for Structure and Binding Affinity Prediction

Researchers at MIT’s Jameel Clinic and CSAIL, in collaboration with Recursion and leveraging NVIDIA’s BioHive-2 supercomputer, have released Boltz-2, an …

Continue ›››

FutureHouse Debuts Scientific Reasoning LLM Model Trained for Chemistry

FutureHouse has released ether0, a 24B-parameter open-weight language model specialized for chemistry tasks. Built on Mistral 24B Instruct and refined …

Continue ›››

The Stage Is Set: London Biotechnology Show 2025

The inaugural London Biotechnology Show (LBS 2024) took place on 8–9 May 2024 at Olympia West, London, and culminated in …

Continue ›››

Kiin Bio Raises $2.2M Pre-Seed to Build AI Platform of "Virtual Scientists" for Drug Discovery

Kiin Bio, a 2024-founded startup developing an AI-native research platform for drug discovery, has raised $2.2 million in pre-seed funding …

Continue ›››

Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond

In this report: Intro: The New Framework “AI Drug Discovery” is About Holism "AI Drug Discovery" is About Building Software …

Continue ›››